These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8654813)

  • 41. GPI 6150, a poly (ADP-ribose) polymerase inhibitor, exhibits an anti-inflammatory effect in rat models of inflammation.
    Mazzon E; Serraino I; Li JH; Dugo L; Caputi AP; Zhang J; Cuzzocrea S
    Eur J Pharmacol; 2001 Mar; 415(1):85-94. PubMed ID: 11245856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
    Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
    Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Influence of poly(ADP-ribose) polymerase inhibitors on some parameters of oxidative stress in blood leukocytes of rats with experimental diabetes].
    Huzyk MM; Diakun KO; Ianits'ka LV; Kuchmerovs'ka TM
    Ukr Biokhim Zh (1999); 2013; 85(1):62-70. PubMed ID: 23534291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?
    Cavone L; Chiarugi A
    Trends Mol Med; 2012 Feb; 18(2):92-100. PubMed ID: 22078487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Poly(ADP-ribosyl)ation and stroke.
    Chiarugi A
    Pharmacol Res; 2005 Jul; 52(1):15-24. PubMed ID: 15911330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A shuttle mechanism for DNA-protein interactions. The regulation of poly(ADP-ribose) polymerase.
    Zahradka P; Ebisuzaki K
    Eur J Biochem; 1982 Oct; 127(3):579-85. PubMed ID: 6293817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase.
    Nduka N; Skidmore CJ; Shall S
    Eur J Biochem; 1980 Apr; 105(3):525-30. PubMed ID: 6245884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The promising role of poly(ADP-ribose) polymerase inhibitors in prostate cancer.
    Aragon-Ching JB
    Asian J Androl; 2016; 18(4):592-3. PubMed ID: 26908063
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of potent nontoxic poly(ADP-Ribose) polymerase-1 inhibitors: chemopotentiation and pharmacological studies.
    Calabrese CR; Batey MA; Thomas HD; Durkacz BW; Wang LZ; Kyle S; Skalitzky D; Li J; Zhang C; Boritzki T; Maegley K; Calvert AH; Hostomsky Z; Newell DR; Curtin NJ
    Clin Cancer Res; 2003 Jul; 9(7):2711-8. PubMed ID: 12855651
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poly(ADP-ribose) polymerase is a zinc metalloenzyme.
    Zahradka P; Ebisuzaki K
    Eur J Biochem; 1984 Aug; 142(3):503-9. PubMed ID: 6088227
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells: role of activation of poly(ADP-ribose)polymerase.
    Kirkland JB
    Biochim Biophys Acta; 1991 May; 1092(3):319-25. PubMed ID: 1904775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological evaluation of substituted 4-(thiophen-2-ylmethyl)-2H-phthalazin-1-ones as potent PARP-1 inhibitors.
    Wang LX; Zhou XB; Xiao ML; Jiang N; Liu F; Zhou WX; Wang XK; Zheng ZB; Li S
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3739-43. PubMed ID: 25086680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase.
    Hattori K; Kido Y; Yamamoto H; Ishida J; Iwashita A; Mihara K
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5577-81. PubMed ID: 17804225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ADP-ribosyltransferase inhibitors and pseudo-substrates inhibit rat smooth muscle cell migration in vitro.
    Saxty B; Yadollahi-Farsani M; Kefalas P; Paul S; MacDermot J
    Biochem Soc Trans; 1998 May; 26(2):S130. PubMed ID: 9649805
    [No Abstract]   [Full Text] [Related]  

  • 55. FGF2-mediated upregulation of urokinase-type plasminogen activator expression requires a MAP-kinase dependent activation of poly(ADP-ribose) polymerase.
    Caldini R; Barletta E; Del Rosso M; Giovannelli L; Chevanne M
    J Cell Physiol; 2005 Jan; 202(1):125-34. PubMed ID: 15389540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biologically relevant O,S-donor compounds. Synthesis, molybdenum complexation and xanthine oxidase inhibition.
    Chaves S; Gil M; Canário S; Jelic R; Romão MJ; Trincão J; Herdtweck E; Sousa J; Diniz C; Fresco P; Santos MA
    Dalton Trans; 2008 Apr; (13):1773-82. PubMed ID: 18354776
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Construction of pharmacophore model of PARP-1 inhibitor].
    Zhang WT; Yan H; Jiang FC
    Yao Xue Xue Bao; 2007 Mar; 42(3):279-85. PubMed ID: 17520827
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase.
    Yau L; Elliot T; Lalonde C; Zahradka P
    Eur J Biochem; 1998 Apr; 253(1):91-100. PubMed ID: 9578465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of Xenopus laevis poly (ADP-ribose) polymerase in oocytes.
    Aoufouchi S; Shall S
    Biochem Soc Trans; 1995 May; 23(2):181S. PubMed ID: 7672205
    [No Abstract]   [Full Text] [Related]  

  • 60. Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.
    Rhee HK; Lim SY; Jung MJ; Kwon Y; Kim MH; Choo HY
    Bioorg Med Chem; 2009 Nov; 17(21):7537-41. PubMed ID: 19800803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.